A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma ModelsHao Zhang, Hyung L. Kim|PLoS ONE|2013Cited by 62
Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor ImmunityYanping Wang, Hyung L. Kim|Clinical Cancer Research|2021Cited by 30
Cholesterol-lowering Decreased mTOR Complex 2 Signaling and Enhanced Antitumor ImmunityYanping Wang, Hyung L. Kim|medRxiv|2021Cited by 1